Eiger To Close After GLP-1 Antagonist Gambit Fails

The company had pivoted towards a drug with the opposite mechanism to Novo Nordisk’s Wegovy, but ran out of time and money.

Eiger Pharmaceuticals

Eiger BioPharmaceuticals has filed for bankruptcy after its long-running financial problems and R&D setbacks came to a head.

The Palo Alto, CA-based company marketed Zokinvy (lonafarnib), the first ever treatment for premature ageing condition Hutchinson-Gilford progeria syndrome, one...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip